Using human samples in proteomics-based drug development: bioethical aspects

Area of Science:

• Biomedical research
• Proteomics
• Medical data analysis

Background:

• Human samples are increasingly vital for application-based biomedical proteomics.
• International regulations and national laws governing human sample research are complex and evolving.
• The use of human samples in research has significant implications for product development and patient rights.

Purpose of the Study:

• To highlight the critical considerations for researchers using human samples in biomedical proteomics.
• To emphasize the heterogeneous international framework conditions for human sample research.
• To underscore the importance of patient rights and informed consent.

Main Methods:

• Review of international and national legal frameworks.
• Analysis of ethical guidelines concerning human sample utilization.
• Examination of the significance of informed consent in research protocols.

Main Results:

• International regulations on human sample use vary significantly.
• National laws are becoming more stringent and are legally binding.
• Informed patient consent is identified as the most crucial ethical and legal requirement.

Conclusions:

• Academic and industrial researchers must be aware of and adhere to diverse legal and ethical standards.
• Respecting patient rights, particularly informed consent, is essential for compliant and ethical biomedical research.
• Navigating the complex legal landscape is critical for advancing proteomics research using human samples.